Cargando…

Hypercoagulability and Anticoagulation in Patients With COVID-19 Requiring Renal Replacement Therapy

Detalles Bibliográficos
Autores principales:	Roberts, Lara N., Bramham, Kate, Sharpe, Claire C., Arya, Roopen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381908/ https://www.ncbi.nlm.nih.gov/pubmed/32838085 http://dx.doi.org/10.1016/j.ekir.2020.07.024

Ejemplares similares

Mode of Delivery Does Not Influence Postpartum Hypercoagulability Measured by Thrombin Generation or Thromboelastometry
por: Guimicheva, Boriana, et al.
Publicado: (2020)

Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy
por: Attallah, Nizar, et al.
Publicado: (2021)

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

Anticoagulated patient’s perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy – study protocol for The Switching Study: a prospective cohort study
por: Auyeung, Vivian, et al.
Publicado: (2016)

EFFECT OF ANTICOAGULATION AND ANTIPLATELET AGENTS ON HYPERCOAGULABILITY STATES IN PATIENTS WITH COVID-19
por: UR, JEANNIE, et al.
Publicado: (2021)

How do anticoagulants impact menstrual bleeding and quality of life? - The PERIOD study
por: Patel, Jignesh P., et al.
Publicado: (2023)

The “lived” experience of menstruating women commencing anticoagulants
por: Sheikh, Umber, et al.
Publicado: (2023)

Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature
por: Watras, Magdalena M., et al.
Publicado: (2016)

Anticoagulation during Renal Replacement Therapy
por: Singh, Simran
Publicado: (2020)

In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
por: Blasi, Annabel, et al.
Publicado: (2020)

Anticoagulation Protocols in Hypercoagulable Microvascular Head and Neck Reconstruction
por: Egan, Katie G., et al.
Publicado: (2019)

Hypercoagulation in COPD: the clot thickens
por: Rahaghi, Farbod N., et al.
Publicado: (2021)

Provision of acute renal replacement therapy, using three separate modalities, in critically ill patients during the COVID-19 pandemic. An after action review from a UK tertiary critical care centre
por: Fisher, Richard, et al.
Publicado: (2021)

Pulmonary embolism in hospitalised patients with COVID-19
por: Whyte, Martin B., et al.
Publicado: (2020)

Association between type of anticoagulation and blood transfusion requirements during renal replacement therapy in the ICU
por: Iyer, A, et al.
Publicado: (2011)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Anticoagulation for hypercoagulability in severe critical COVID-19: A case series of fading and fatal cycles of microthrombosis
por: Ronderos Botero, Diana Maria, et al.
Publicado: (2021)

A Case Series of Thromboelastography-Guided Anticoagulation in COVID-19 Patients with Inherited and Acquired Hypercoagulable States
por: Thomas, Anthony V., et al.
Publicado: (2021)

Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines
por: Abdel-Bakky, Mohamed S., et al.
Publicado: (2022)

Hypercoagulability following COVID-19 infection: at what stage is it safe to do a free flap?
por: Kanatas, A., et al.
Publicado: (2020)

Thromboelastogram to Detect Hypercoagulability in Critically Ill COVID-19 Patients: Has Its Time Come?
por: Venkataraman, Ramesh
Publicado: (2020)

Venous thromboembolism in patients hospitalised with COVID-19 in England
por: Roberts, Lara N., et al.
Publicado: (2022)

Acute Renal Replacement Therapy
por: Jörres, Achim, et al.
Publicado: (2011)

Hypercoagulability in COVID-19: from an unknown beginning to future therapies
por: Duca, Ştefania-Teodora, et al.
Publicado: (2022)

Hypercoagulable State and Thrombosis of Bioprosthetic Transcatheter Aortic Valve Replacement (TAVR) Refractory to Common Anticoagulation Methods in the Setting of Protein S Deficiency
por: Kellam, Caleb J, et al.
Publicado: (2023)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

Hypercoagulable state in COVID-19 with diabetes mellitus and obesity: Is therapeutic-dose or higher-dose anticoagulant thromboprophylaxis necessary?
por: Wijaya, Indra, et al.
Publicado: (2020)

Switching warfarin patients to a direct oral anticoagulant during the Coronavirus Disease-19 pandemic
por: Patel, Rachna, et al.
Publicado: (2021)

Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation
por: Chandel, Abhimanyu, et al.
Publicado: (2021)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Citrate anticoagulation for continuous renal replacement therapy in small children
por: Soltysiak, Jolanta, et al.
Publicado: (2013)

Regional citrate anticoagulation for continuous renal replacement therapy in newborns
por: Huang, Haixia, et al.
Publicado: (2023)

Factors influencing the recruitment of lactating women in a clinical trial involving direct oral anticoagulants: a qualitative study
por: Zhao, Yating, et al.
Publicado: (2018)

Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy
por: Bouchard, Josée, et al.
Publicado: (2009)

Assessment of body fluid in critically ill patients with acute kidney injury requiring continuous renal replacement therapy
por: Kim,, Jae Seok, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b93u5kl859jgpc7trepf29vhsa